Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Licenses RT-PCR for Thermal Cyclers

NEW YORK, June 23 (GenomeWeb News) - Cepheid has expanded its license to Applera's core PCR patents to include real-time PCR for applications in thermal cyclers, the companies said today.

Cepheid has obtained a non-exclusive global license to make, use, and sell its SmartCycler and GeneXpert brand thermal cyclers, as well as other Cepheid thermal cyclers, using Applera's real-time PCR technology.

Additionally, with a payment of $11.5 million over a two-year period, Cepheid expands its rights under its existing thermal-cycler supplier agreement with Applera to include human diagnostics but not HIV and Hepatitis C applications.


The licensing deal was announced as Applera's Applied Biosystems group obtained injunctions to halt the manufacture and sale of RT-PCR thermal cyclers by a group of companies. For details, click here.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.